Cour Pharmaceuticals Development
Max Peskin is an Analytical Chemist with experience at Nexus Pharmaceuticals, Inc. since March 2022 and previously at AbbVie from August 2020 to March 2022. At Purdue University, Max served as a Teaching Assistant for a cellular biology lab from April 2019 to June 2021, instructing students in scientific methods, lab safety, and lab procedures, while also preparing reagents and chemicals. Max holds a Bachelor's degree in Biochemistry from Purdue University, completed in 2020.
This person is not in any teams
Cour Pharmaceuticals Development
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.